Plöntuútdrættir

Plöntuþykkni vísar til plöntuafurða með litlum líffræðilegum sameindum og stórsameindum sem meginhluta sem myndaður er í þeim tilgangi að aðskilja og hreinsa eitt eða fleiri virk efni í plöntuhráefnum með eðlisfræði, efnafræði og líffræði.

Plöntuþykkni eins og vínberafræseyði, magnolia geltaþykkni, tómatseyði, Citrus aurantium þykkni, kirsuberjaþykkni, aloe vera þykkni, ginkgo biloba þykkni, græna kaffibaunaþykkni, eucommia ulmoides þykkni og önnur plöntuþykkni hefur verið mikið notaður. Það er notað við framleiðslu á grasaefnum, matvælaaukefnum, hagnýtum matvælum, daglegum efnum, grasafræðilegum skordýraeitri og dýralyfjum.

Plant extract products have been warmly respected around the world, showing a strong growth momentum. According to customs data, in 2002, the export value of my country's plant extract industry was only 200 million US dollars. By 2011, it had exceeded 1 billion US dollars and reached 1.130 billion US dollars. In 2014, the export value of my country's plant extracts (Shanghe Biological) jumped to 1.778 billion U.S. dollars, an increase of 25.88 percent year-on-year, and the development speed is fast. In the first half of 2015, my country's export of plant extract products was US1.09 billion, accounting for 56.38 percent of my country's total export of Chinese medicine. Shanghe Biology-Plant Extract-Magnolia Bark Extract at the "2015 CNIC China International Forum on Plant Extracts (Beijing) Small Seminar", Yu Zhibin, Secretary-General of the Plant Extract Branch of the China Chamber of Commerce for Import and Export of Medicines and Health Products, said in 2015. In half a year, my country's export of plant extracts to the United States ranked first, accounting for 19 percent of total exports; second was exports to Japan, accounting for 10 percent of exports; and third was exports to Indonesia and Malaysia, each accounting for total exports. Of 9 percent .

Statistics from the China Chamber of Commerce for Import and Export of Medicines and Health Products show that in 2014, my country's export of plant extracts was US1.778 billion, accounting for 49.48 percent of my country's exports of traditional Chinese medicine products, a year-on-year increase of 25.88 percent . "In recent years, extracts have accounted for an increasing proportion of my country's traditional Chinese medicine exports, far higher than the export growth rate of my country's medicines and health products and traditional Chinese medicine products, and has become the most rapidly developing new and expensive industry in the export of Chinese medicine products." Yu Zhibin said.

Það er litið svo á að efstu tíu séu: stevía þykkni, bláberjaþykkni, tröllatrésolía, papriku litarefni, kanilolía, lakkrísseyði, marigold þykkni, Luo Han Guo þykkni, mjólkurþistillseyði og reyr Ding, þar af flytja aðeins stevíuþykkni út meira en 100 milljónir Bandaríkjadala.

Herliðið í Bandaríkjunum heldur áfram að leiða markaðinn. Nú á dögum er inntaka fæðubótarefna lífsvenja flestra Bandaríkjamanna, sem er einnig mikilvæg ástæða fyrir því að eftirspurn eftir plöntuþykkni í Bandaríkjunum hefur verið mikil. Til dæmis flytja Bandaríkin inn mikið magn af ginkgo biloba og grænu teþykkni frá mínu landi.

Japan, closely behind the United States, has consistently ranked second for ten consecutive years. It is reported that in the first half of 2015, my country's export of plant extracts (Shanghe Biological) to Japan reached 109 million US dollars, accounting for 10 percent . Indonesia and Malaysia, tied for third place, are both rising stars in the past two years, and they mainly love Chinese essential oil extracts. Yu Zhibin revealed that Indonesia's imports of plant extracts increased by 80.57 percent in 2014, and Malaysia's increased by more than 40 percent .